Diagnostic Performance of 1,5-Anhydroglucitol Compared to 2-H Glucose in the Atherosclerosis Risk in Communities Study.
作者信息
Warren Bethany, Lee Alexandra K, Ballantyne Christie M, Hoogeveen Ron C, Pankow James S, Grams Morgan, Köttgen Anna, Selvin Elizabeth
机构信息
Department of Epidemiology Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Department of Medicine Baylor College of Medicine Houston, TX.
出版信息
Clin Chem. 2018 Oct;64(10):1536-1537. doi: 10.1373/clinchem.2018.291773. Epub 2018 Aug 7.
Abstract
摘要
相似文献
1
Diagnostic Performance of 1,5-Anhydroglucitol Compared to 2-H Glucose in the Atherosclerosis Risk in Communities Study.
Clin Chem. 2018 Oct;64(10):1536-1537. doi: 10.1373/clinchem.2018.291773. Epub 2018 Aug 7.
2
[1,5-anhydroglucitol].
Nihon Rinsho. 2002 Aug;60 Suppl 8:410-4.
3
Screening for type 2 diabetes in obese youth.
Pediatrics. 2009 Aug;124(2):573-9. doi: 10.1542/peds.2008-2949. Epub 2009 Jul 20.
4
Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
Clin Chem. 2012 Dec;58(12):1648-55. doi: 10.1373/clinchem.2012.188367. Epub 2012 Sep 27.
5
Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol, With Subclinical Cardiovascular Disease.
Diabetes Care. 2016 Oct;39(10):1752-9. doi: 10.2337/dc16-0840. Epub 2016 Aug 1.
6
Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.
Am J Epidemiol. 2017 Oct 15;186(8):952-960. doi: 10.1093/aje/kwx167.
7
Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.
Diabet Med. 2017 Oct;34(10):1407-1413. doi: 10.1111/dme.13391. Epub 2017 Jul 9.
8
Lower 1,5-anhydroglucitol is associated with denovo coronary artery disease in patients at high cardiovascular risk.
Heart Vessels. 2015 Jul;30(4):469-76. doi: 10.1007/s00380-014-0502-y. Epub 2014 Apr 2.
9
Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests.
Endocr J. 2011;58(1):13-7. doi: 10.1507/endocrj.k10e-224. Epub 2010 Nov 12.
10
Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
Diabetes Technol Ther. 2013 Jun;15(6):455-60. doi: 10.1089/dia.2012.0315. Epub 2013 Apr 25.
引用本文的文献
1
The clinical potential of 1,5-anhydroglucitol as biomarker in diabetes mellitus.
Front Endocrinol (Lausanne). 2024 Oct 31;15:1471577. doi: 10.3389/fendo.2024.1471577. eCollection 2024.
2
Associations of 1,5-Anhydroglucitol and 2-Hour Glucose with Major Clinical Outcomes in the Atherosclerosis Risk in Communities (ARIC) Study.
J Appl Lab Med. 2020 Nov 1;5(6):1296-1306. doi: 10.1093/jalm/jfaa066.
3
Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study.
Sci Rep. 2019 Apr 11;9(1):5941. doi: 10.1038/s41598-019-42202-0.
本文引用的文献
1
Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism.
Sci Rep. 2017 Jun 6;7(1):2812. doi: 10.1038/s41598-017-02287-x.
2
Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.
Diabet Med. 2017 Oct;34(10):1407-1413. doi: 10.1111/dme.13391. Epub 2017 Jul 9.
3
Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests.
Endocr J. 2011;58(1):13-7. doi: 10.1507/endocrj.k10e-224. Epub 2010 Nov 12.
4
Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus.
Diabetes. 1991 Jan;40(1):52-7. doi: 10.2337/diab.40.1.52.
5
Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body.
Am J Physiol. 1992 Aug;263(2 Pt 1):E268-73. doi: 10.1152/ajpendo.1992.263.2.E268.
Zotero 插件